| Charter Hall Long Wale REIT (CLW) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$2,922 |
Update - Notification of buy-back - CLW
|
10 Dec 2024 9:25AM |
$3.800 |
$4.100 |
risen by
7.89%
|
|
| James Bay Minerals Limited (JBY) ORDINARY FULLY PAID |
Materials |
- |
4% Cu and 6,874g/t Ag in historic drilling at Independence
|
10 Dec 2024 9:25AM |
$0.660 |
$0.540 |
fallen by
18.18%
|
|
JBY - Price-sensitive ASX Announcement
Full Release
Key Points
- Up to 4% Copper (Cu) and 6,874g/t Silver (Ag) in historic drilling.
- Intrusion-related mineralisation identified across the Independence Project.
- 38 drill holes with intercepts equal to or exceeding 100g/t Ag.
- High-grade silver results capped at 100g/t due to assay limits.
- Detailed mapping revealed multiple mineralised events across the project area.
- James Bay Minerals is acquiring a majority interest in the Independence Project.
- Initial drilling of approximately 2,000m is currently underway.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Doctor Care Anywhere Group PLC (DOC) CHESS DEPOSITARY INTERESTS 1:1 |
Health Care |
$48 |
Leadership Evolution for 2025 and Beyond
|
10 Dec 2024 9:25AM |
$0.065 |
$0.130 |
risen by
100%
|
|
DOC - Price-sensitive ASX Announcement
Full Release
Key Points
- Laura O’Riordan appointed CEO effective January 6, 2025.
- Laura has extensive experience in leadership and digital healthcare.
- John Stier, Chair of Doctor Care Anywhere, expressed confidence in Laura's leadership.
- Ben Kent will step down as CEO but will assist during the transition.
- Two non-executive directors will retire by the end of December 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Anteris Technologies Ltd (AVR) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$231 |
ATGC Announces Launch of U.S. Initial Public Offering
|
10 Dec 2024 9:24AM |
$10.540 |
$6.020 |
fallen by
42.88%
|
|
AVR - Price-sensitive ASX Announcement
Full Release
Key Points
- ATGC is conducting a U.S. Initial Public Offering of 14,800,000 shares.
- An option for underwriters to purchase an additional 2,220,000 shares is included.
- Proceeds will fund the development of the DurAVR® transcatheter heart valve.
- The offering aims to support a global pivotal study for aortic stenosis treatment.
- ATGC will seek to list its shares on the Nasdaq under the ticker symbol 'AVR'.
- CHESS Depositary Interests will also be listed on the ASX under 'AVR'.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Praemium Limited (PPS) ORDINARY FULLY PAID |
Information Technology |
$414 |
Update - Notification of buy-back - PPS
|
10 Dec 2024 9:23AM |
$0.780 |
$0.865 |
risen by
10.90%
|
|
| Coast Entertainment Holdings Limited (CEH) ORDINARY FULLY PAID |
Consumer Discretionary |
$190 |
Update - Notification of buy-back - CEH
|
10 Dec 2024 9:23AM |
$0.460 |
$0.490 |
risen by
6.52%
|
|
| ReNerve Limited (RNV) ORDINARY FULLY PAID |
Health Care |
$13 |
Exclusive Partnership with Supplier in the Middle East
|
10 Dec 2024 9:22AM |
$0.170 |
$0.115 |
fallen by
32.35%
|
|
RNV - Price-sensitive ASX Announcement
Full Release
Key Points
- ReNerve Limited partners with Union MediScience for exclusive distribution in the Middle East.
- The agreement includes five countries: Bahrain, Saudi Arabia, Kuwait, UAE/Dubai, and Qatar.
- Union MediScience has a strong reputation as a medical device distributor in the region.
- The global nerve repair biomaterials market is projected to grow significantly.
- This partnership supports ReNerve's strategic global expansion and market entry.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| archTIS Limited (AR9) ORDINARY FULLY PAID |
Information Technology |
$50 |
AR9 Signs $704,000 Contract with Accenture
|
10 Dec 2024 9:22AM |
$0.062 |
$0.105 |
risen by
69.35%
|
|
| Capitol Health Limited (CAJ) ORDINARY FULLY PAID |
Health Care |
- |
AXX: IDX acquisit'n of CAJ unopposed, subject to divestiture
|
10 Dec 2024 9:22AM |
$0.370 |
$0.385 |
risen by
4.05%
|
|
CAJ - Price-sensitive ASX Announcement
Full Release
Key Points
- Integral Diagnostics' acquisition of Capitol Health is not opposed by the ACCC.
- The acquisition is conditional on divesting Capitol Health's Melton clinic.
- The merger would reduce competition in the Melton region's diagnostic imaging services.
- The ACCC aims to maintain viable competition in the local market.
- Integral Diagnostics will acquire 60 radiology sites across multiple regions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Integral Diagnostics Limited (IDX) ORDINARY FULLY PAID |
Health Care |
$985 |
AXX: IDX acquisit'n of CAJ unopposed, subject to divestiture
|
10 Dec 2024 9:22AM |
$2.900 |
$2.640 |
fallen by
8.97%
|
|
IDX - Price-sensitive ASX Announcement
Full Release
Key Points
- ACCC will not oppose Integral Diagnostics' acquisition of Capitol Health.
- Divestiture of Capitol Health’s radiology clinic in Melton is required.
- Integral Diagnostics will acquire 60 radiology sites across Australia.
- The divestment is necessary to maintain competition in the Melton region.
- ACCC satisfied that the acquisition won't raise substantial competition concerns in other areas.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Riedel Resources Limited (RIE) ORDINARY FULLY PAID |
Materials |
$4 |
Completion of Consolidation
|
10 Dec 2024 9:21AM |
$0.035 |
$0.028 |
fallen by
20%
|
|
RIE - Price-sensitive ASX Announcement
Full Release
Key Points
- Riedel Resources Limited has completed a capital consolidation.
- Consolidation ratio was set at 1 for 40.
- Shareholder approval was obtained on 27 November 2024.
- The updated capital structure includes 55,596,079 fully paid ordinary securities.
- Several unlisted options are part of the new capital structure.
- New holding statements will be dispatched to securityholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Fortescue Ltd (FMG) ORDINARY FULLY PAID |
Materials |
$65,921 |
FY24 Modern Slavery Statement
|
10 Dec 2024 9:21AM |
$19.250 |
$21.410 |
risen by
11.22%
|
|
| Senetas Corporation Limited (SEN) ORDINARY FULLY PAID |
Information Technology |
$41 |
Notification of cessation of securities - SEN
|
10 Dec 2024 9:20AM |
$0.023 |
$0.025 |
risen by
8.70%
|
|
| Traka Resources Limited (TKL) ORDINARY FULLY PAID |
Materials |
$6 |
Cleansing Notice
|
10 Dec 2024 9:19AM |
$0.001 |
$0.003 |
risen by
150%
|
|
| Insignia Financial Ltd (IFL) ORDINARY FULLY PAID |
Financials |
$3,052 |
IFL unveils plans to transform Master Trust business
|
10 Dec 2024 9:19AM |
$3.030 |
$4.550 |
risen by
50.17%
|
|
| Godolphin Resources Limited (GRL) ORDINARY FULLY PAID |
Materials |
$10 |
Significant progress on Narraburra REE Project
|
10 Dec 2024 9:18AM |
$0.014 |
$0.014 |
fallen by
0%
|
|
GRL - Price-sensitive ASX Announcement
Full Release
Key Points
- Second Mixed Rare Earth Carbonate (MREC-2) successfully produced from Narraburra REE Project.
- MREC-2 has similar MREO contents and considerably less impurities than MREC-1.
- Ion Exchange process removed 98% of uranium from the purified leach solution.
- MREC-2 contains lower impurities than most other clay-hosted REE projects.
- Both MREC products provide GRL with the ability to commence discussions with potential off-take partners.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Butn Limited (BTN) ORDINARY FULLY PAID |
Financials |
$33 |
Change of Director's Interest Notice
|
10 Dec 2024 9:17AM |
$0.082 |
$0.087 |
risen by
6.10%
|
|
| TechGen Metals Ltd (TG1) ORDINARY FULLY PAID |
Materials |
$11 |
Option Agreement NT Copper Project
|
10 Dec 2024 9:15AM |
$0.034 |
$0.029 |
fallen by
14.71%
|
|
TG1 - Price-sensitive ASX Announcement
Full Release
Key Points
- TechGen has signed an Option Agreement for the Blue Bore Copper Project.
- The company aims to acquire an 80% interest in the project.
- The project is located in an unexplored region of the Northern Territory.
- Historical data shows anomalous copper levels in a water sample.
- The geological conditions are favorable for sediment-hosted copper deposits.
- The project offers a first-mover advantage in an untouched region.
- TechGen's strategy focuses on high-potential copper assets.
- There is significant interest in copper due to global decarbonization efforts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gold Mountain Limited (GMN) ORDINARY FULLY PAID |
Materials |
$11 |
More Olympic Dam style IOCG Copper mineralisation at Iguatu
|
10 Dec 2024 9:15AM |
$0.004 |
$0.060 |
risen by
1,400%
|
|
| WAM Leaders Limited (WLE) ORDINARY FULLY PAID |
Financials |
$1,762 |
Kate Thorley Appendix 3Y
|
10 Dec 2024 9:13AM |
$1.230 |
$1.280 |
risen by
4.07%
|
|
| Insurance Australia Group Limited (IAG) ORDINARY FULLY PAID |
Financials |
$18,355 |
IAG to defend class action
|
10 Dec 2024 9:12AM |
$8.650 |
$7.760 |
fallen by
10.29%
|
|
| FBR Ltd (FBR) ORDINARY FULLY PAID |
Industrials |
$27 |
Cleansing Notice
|
10 Dec 2024 9:12AM |
$0.036 |
$0.004 |
fallen by
88.89%
|
|
| Incitec Pivot Limited (IPL) ORDINARY FULLY PAID |
Materials |
$4,827 |
Update - Notification of buy-back - IPL
|
10 Dec 2024 9:12AM |
$3.110 |
$2.590 |
fallen by
16.72%
|
|
| Neuren Pharmaceuticals Limited (NEU) ORDINARY FULLY PAID |
Health Care |
$2,487 |
Update - Notification of buy-back - NEU
|
10 Dec 2024 9:12AM |
$12.740 |
$19.640 |
risen by
54.16%
|
|
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$710 |
Unitholder Monthly Report for November 2024
|
10 Dec 2024 9:12AM |
$3.400 |
$3.360 |
fallen by
1.18%
|
|